You are here

Singapore stops enrolment for Covid-19 antibody trial after US drugmaker halts trial

[SINGAPORE] The National Centre for Infectious Diseases (NCID) has temporarily stopped enrolling Covid-19 patients for a monoclonal antibody trial after the American pharmaceutical company that developed the drug had to halt the trial due to safety concerns last week.

Singapore is only...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes